FBB
CELG

Fulton Breakefield Broenniman’s Celgene Corp CELG Stock Holding History

Fulton Breakefield Broenniman’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-28,243
Closed -$3.26M – 135
2015
Q1 		$3.26M Buy
28,243
+3,090
+12% +$369K 0.72% 55
2014
Q4 		$2.81M Sell
25,153
-115
-0.5% -$12.1K 0.62% 63
2014
Q3 		$2.4M Buy
25,268
+210
+0.8% +$19K 0.56% 67
2014
Q2 		$2.15M Buy
25,058
+270
+1% +$20.5K 0.52% 66
2014
Q1 		$1.73M Buy
24,788
+1,002
+4% +$79.3K 0.45% 71
2013
Q4 		$2.01M Sell
23,786
-740
-3% -$58.6K 0.53% 65
2013
Q3 		$1.89M Buy
24,526
+430
+2% +$30.1K 0.51% 69
2013
Q2 		$1.41M Buy
+24,096
New +$1.45M 0.41% 79

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fulton Breakefield Broenniman's CELG Position: Q2 2015 in Review

Fulton Breakefield Broenniman sold out of Celgene Corp (CELG) in Q2 2015, closing a stake of 28,243 shares — an estimated $3.26M sold.

Fulton Breakefield Broenniman first reported a position in CELG in Q2 2013 and held it in 8 quarters. The position peaked at $3.26M in Q1 2015. 1,201 funds tracked by Wall St. Rank hold CELG as of Q2 2015.

  • Fulton Breakefield Broenniman reported no remaining Celgene Corp position as of Q2 2015 after selling out during the quarter.
  • Fulton Breakefield Broenniman sold 28,243 Celgene Corp shares in Q2 2015, an estimated $3.26M.
  • Fulton Breakefield Broenniman first reported a position in Celgene Corp in Q2 2013 and held it in 8 quarters.
  • Fulton Breakefield Broenniman's Celgene Corp position peaked at $3.26M in Q1 2015.
  • 1,201 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2015.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2015, filed 4 Aug 2015.